vs
Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
Bioceres Crop Solutions Corp. is the larger business by last-quarter revenue ($77.6M vs $75.5M, roughly 1.0× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -16.8%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -8.4%).
Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
BIOX vs PBYI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $77.6M | $75.5M |
| Net Profit | $-7.4M | — |
| Gross Margin | 46.8% | 69.3% |
| Operating Margin | 9.3% | 22.7% |
| Net Margin | -9.6% | — |
| Revenue YoY | -16.8% | 27.7% |
| Net Profit YoY | -20.2% | — |
| EPS (diluted) | $-0.12 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $75.5M | ||
| Q3 25 | $77.6M | $54.5M | ||
| Q2 25 | — | $52.4M | ||
| Q1 25 | $60.6M | $46.0M | ||
| Q4 24 | $98.8M | $59.1M | ||
| Q3 24 | $93.3M | $80.5M | ||
| Q2 24 | — | $47.1M | ||
| Q1 24 | $84.0M | $43.8M |
| Q4 25 | — | — | ||
| Q3 25 | $-7.4M | $8.8M | ||
| Q2 25 | — | $5.9M | ||
| Q1 25 | $-1.6M | $3.0M | ||
| Q4 24 | $605.2K | — | ||
| Q3 24 | $-6.2M | $20.3M | ||
| Q2 24 | — | $-4.5M | ||
| Q1 24 | $9.8M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | 46.8% | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | 39.4% | 77.1% | ||
| Q4 24 | 42.0% | 76.4% | ||
| Q3 24 | 40.2% | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | 50.8% | 75.5% |
| Q4 25 | — | 22.7% | ||
| Q3 25 | 9.3% | 17.6% | ||
| Q2 25 | — | 12.7% | ||
| Q1 25 | 1.5% | 8.7% | ||
| Q4 24 | 14.5% | 22.6% | ||
| Q3 24 | 2.5% | 27.4% | ||
| Q2 24 | — | -4.6% | ||
| Q1 24 | 15.7% | -5.3% |
| Q4 25 | — | — | ||
| Q3 25 | -9.6% | 16.2% | ||
| Q2 25 | — | 11.2% | ||
| Q1 25 | -2.6% | 6.5% | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | -6.6% | 25.2% | ||
| Q2 24 | — | -9.6% | ||
| Q1 24 | 11.6% | -11.0% |
| Q4 25 | — | $0.26 | ||
| Q3 25 | $-0.12 | $0.17 | ||
| Q2 25 | — | $0.12 | ||
| Q1 25 | $-0.02 | $0.06 | ||
| Q4 24 | $0.00 | $0.40 | ||
| Q3 24 | $-0.10 | $0.41 | ||
| Q2 24 | — | $-0.09 | ||
| Q1 24 | $0.14 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $15.5M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $288.3M | $130.3M |
| Total Assets | $734.9M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $97.5M | ||
| Q3 25 | $15.5M | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | $38.5M | $93.2M | ||
| Q4 24 | $29.2M | $101.0M | ||
| Q3 24 | $32.3M | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | $16.4M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | — | $130.3M | ||
| Q3 25 | $288.3M | $115.3M | ||
| Q2 25 | — | $104.7M | ||
| Q1 25 | $345.0M | $97.1M | ||
| Q4 24 | $346.3M | $92.1M | ||
| Q3 24 | $346.0M | $71.1M | ||
| Q2 24 | — | $48.5M | ||
| Q1 24 | $348.5M | $51.0M |
| Q4 25 | — | $216.3M | ||
| Q3 25 | $734.9M | $202.9M | ||
| Q2 25 | — | $194.9M | ||
| Q1 25 | $798.2M | $196.2M | ||
| Q4 24 | $835.2M | $213.3M | ||
| Q3 24 | $827.3M | $220.7M | ||
| Q2 24 | — | $205.0M | ||
| Q1 24 | $836.1M | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | $14.4M |
| Free Cash FlowOCF − Capex | — | $14.4M |
| FCF MarginFCF / Revenue | — | 19.1% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $14.4M | ||
| Q3 25 | $14.4M | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | $23.3M | $3.6M | ||
| Q4 24 | $-5.4M | $15.6M | ||
| Q3 24 | $5.2M | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | $-17.4M | $11.2M |
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | -8.85× | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | -1.78× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
